Coverage
-
April 06, 2015
Novartis Pharmaceuticals Corp. will pay $12.25 million and royalties to Juno Therapeutics Inc. to settle a three-year-old patent dispute over cancer immunotherapy drugs between a university and a hospital with which they struck licensing deals, the parties said on Monday.
1 other articles on this case.
View all »